P/E ratio for Cryo-Cell (CCEL)
P/E ratio as of May 2024 (TTM): 28.6
According to Cryo-Cell's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 28.5667. At the end of 2022 the company had a P/E ratio of 12.4.
P/E ratio history for Cryo-Cell from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 12.4 | -72.11% |
| 2021 | 44.6 | 178.12% |
| 2020 | 16.0 | -34.75% |
| 2019 | 24.6 | -142.62% |
| 2018 | -57.7 | -296.88% |
| 2017 | 29.3 | -228.52% |
| 2016 | -22.8 | -719.88% |
| 2015 | 3.68 | -92.49% |
| 2014 | 49.0 | -93.31% |
| 2013 | 733 | -19637.95% |
| 2012 | -3.75 | -68.13% |
| 2011 | -11.8 | -237.25% |
| 2010 | 8.57 | -37.4% |
| 2009 | 13.7 | -295.6% |
| 2008 | -7.00 | 281.01% |
| 2007 | -1.84 | -80.66% |
| 2006 | -9.50 | -125.15% |
| 2005 | 37.8 | 119.64% |
| 2004 | 17.2 | -1551.95% |
| 2003 | -1.18 | -62.17% |
| 2002 | -3.13 | -105.75% |
| 2001 | 54.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Omnicell
OMCL | -38.0 | -233.16% | 🇺🇸 USA |
 Global Cord Blood CORBF | 1.95 | -93.19% | 🇭🇰 Hong Kong |
 CorVel Corporation
CRVL | 55.4 | 93.95% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.